Physician profile
Akilis M Theoharidis
NPI 1912933474
$99,643.11
in general payments reported to CMS, 2019-2025
15 companies · $5,385 in 2025
The $5,385 reported for 2025 was more than what 98% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.10 · 2020: $36.67 · 2021: $5,474 · 2022: $56K · 2023: $16K · 2024: $16K · 2025: $5,385.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $34K · Travel and Lodging: $2,040 · Food and Beverage: $1,009 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $963 · Education: $14.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $33,692.50 |
| Travel and Lodging | $2,040.36 |
| Food and Beverage | $1,009.15 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $962.50 |
| Education | $14.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $61,765.75 | 2020-2022 | |
| Averitas Pharma INC. | $37,246.06 | 2023-2025 | Qutenza |
| Mimedx Group, INC. | $166.92 | 2024-2025 | |
| Advanced Oxygen Therapy INC. | $83.25 | 2022 | |
| Bone Support INC. | $56.88 | 2024 | Cerament G, Ceramentbone Void Filler |
| Polynovo North America LLC | $55.62 | 2024 | Novosorb Btm |
| Ani Pharmaceuticals, INC. | $48.52 | 2025 | Purified Cortrophin Gel |
| Smith+Nephew, INC. | $47.99 | 2024-2025 | Bone Anchors With Arthroscopic Delivery System, Q-Fix, Pico 7 |
| Stryker Corporation | $43.53 | 2024 | Actishield, N/A |
| Janssen Pharmaceuticals, INC | $30.60 | 2021 | |
| Depuy Synthes Sales INC. | $27.96 | 2024 | Motoband |
| Vertex Pharmaceuticals Incorporated | $25.73 | 2025 | |
| Aroa Biosurgery Incorporated | $25.10 | 2019 | |
| Celularity INC. | $16.53 | 2020 | |
| Musculoskeletal Transplant Foundation INC. | $2.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Akilis Theoharidis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.